4.6 Article

Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy

Journal

JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 11, Issue 4, Pages 679-685

Publisher

WILEY-BLACKWELL
DOI: 10.1111/jth.12150

Keywords

anticoagulant therapy; clot resolution; CT-scan; perfusion scintigraphy; pulmonary embolism

Ask authors/readers for more resources

Introduction Little is known about the natural history of clot resolution in the initial weeks of anticoagulant therapy in patients with acute pulmonary embolism (PE). Clot resolution of acute PE was assessed with either computed tomography pulmonary angiography scan (CT-scan) or perfusion scintigraphy scan (Q-scan) after 3weeks of treatment. Methods This was a predefined safety analysis of the Einstein PE study, including PE patients, randomized to either enoxaparin with vitaminK antagonist (VKA) or rivaroxaban. A similar scan as at baseline was repeated after 3weeks. The percentage of vascular obstruction (PVO) was calculated on the basis of a weighted semiquantitative estimation of obstruction. Clot resolution was assessed blindly by calculating the relative change after 3weeks. Results PE was diagnosed in 264 patients with CT-scan and in 83 with Q-scan. Baseline characteristics were similar. At baseline, the mean PVO assessed with CT-scan (PVO-CT) and the mean PVO assessed with Q-scan (PVO-Q) were both 21% (standard deviation [SD]13%) (P=0.9). The mean relative decrease in PVO was 71% (SD33%) for PVO-CT, and 62% (SD36%) for PVO-Q (P=0.02); complete resolution was observed in 44% (116/264; 95% confidence interval [CI]3850%) and 31% (26/83; 95%CI2242%) with CT-scan and Q-scan, respectively (P=0.04). No difference in clot resolution between enoxaparin/VKA and rivaroxaban was found. Conclusion In patients with acute PE, only 3weeks of anticoagulant treatment leads to complete clot resolution in a considerable proportion of patients, and normalization is more often observed with CT-scan than with Q-scan.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

All Staphylococcus aureus bacteraemia-inducing strains can cause infective endocarditis: Results of GWAS and experimental animal studies

Sylvere Bastien, Severien Meyers, Wilmara Salgado-Pabon, Stefano G. Giulieri, Jean-Phillipe Rasigade, Laurens Liesenborghs, Kyle J. Kinney, Florence Couzon, Patricia Martins-Simoes, Vincent Le Moing, Xavier Duval, Natasha E. Holmes, Niels Eske Bruun, Robert Skov, Benjamin P. Howden, Vance G. Fowler, Peter Verhamme, Paal Skytt Andersen, Coralie Bouchiat, Karen Moreau, Francois Vandenesch

Summary: Through a genome-wide association study and experimental animal models, it was found that specific S. aureus strains causing bloodstream infection do not necessarily cause infective endocarditis. Therefore, all S. aureus strains isolated from patients with bloodstream infection should be considered capable of causing this common and deadly infection.

JOURNAL OF INFECTION (2023)

Editorial Material Obstetrics & Gynecology

Intermediate-Dose Versus Low-Dose Low-Molecular-Weight Heparin in Pregnant and Post-Partum Women with a History of Venous Thromboembolism (Highlow Study): An Open-Label, Multicentre, Randomised, Controlled Trial

Ingrid Bistervels, Andrea Buchmueller, Hanke M. G. Wiegers, Fionnuala Ni Ainle, Bernard Tardy, Jennifer Donnelly, Peter F. Verhamme, Anne T. Jacobsen, Anette A. Hansen, Marc T. Rodger, Maria G. DeSancho, Roman Shmakov, Nick van Es, Martin H. Prins, Celine Chauleur, Saskia Middeldorp

Summary: Venous thromboembolism (VTE) is a major concern during pregnancy and its prevention with medical thromboprophylaxis can cause bleeding complications. This study found that low-dose heparin is effective in preventing VTE recurrence in pregnant women with a history of VTE, with no significant difference in bleeding risk compared to intermediate-dose heparin.

OBSTETRICAL & GYNECOLOGICAL SURVEY (2023)

Article Oncology

Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction

Tzu-Fei Wang, Alok A. Khorana, Giancarlo Agnelli, Dan Bloomfield, Marc P. Bonaca, Harry R. Buller, Jean M. Connors, Shinya Goto, Zhi-Cheng Jing, Ajay K. Kakkar, Yasser Khder, Gary E. Raskob, Gerald A. Soff, Peter Verhamme, Jeffrey Weitz, Marc Carrier

Summary: Cancer-associated thrombosis, a condition with increasing incidence, has significant morbidity and mortality in cancer patients. Recent advances in its treatment include the use of direct oral anticoagulants (DOACs) which are more convenient and effective than low-molecular-weight heparin (LMWH). However, there are still unmet needs and concerns about bleeding risk, drug-drug interactions, and management of patients with severe renal impairment.

ONCOLOGIST (2023)

Article Hematology

Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis

Asim Cengiz Akbulut, Ryanne A. Arisz, Constance C. F. M. J. Baaten, Gaukhar Baidildinova, Aarazo Barakzie, Rupert Bauersachs, Jur Ten Berg, Wout W. A. van den Broek, H. C. de Boer, Amandine Bonifay, Vanessa Broker, Richard J. Buka, Hugo ten Cate, Arina J. ten Cate-Hoek, S. Cointe, Ciro De Luca, Ilaria De Simone, Rocio Vacik Diaz, Francoise Dignat-George, Kathleen Freson, Giulia Gazzaniga, Eric C. M. van Gorp, Anxhela Habibi, Yvonne M. C. Henskens, Aaron F. J. Iding, Abdullah Khan, Gijsje H. Koenderink, Akhil Konkoth, Romaric Lacroix, Trisha Lahiri, Wilbur Lam, Rachel E. Lamerton, Roberto Lorusso, Qi Luo, Coen Maas, Owen J. T. McCarty, Paola E. J. van der Meijden, Joost C. M. Meijers, Adarsh K. Mohapatra, Neta Nevo, Alejandro Pallares Robles, Philippe Poncelet, Christoph Reinhardt, Wolfram Ruf, Ronald Saraswat, Claudia Schonichen, Roger Schutgens, Paolo Simioni, Stefano Spada, Henri M. H. Spronk, Karlygash Tazhibayeva, Jecko Thachil, Rocio Vacik Diaz, L. Vallier, Alicia Veninga, Peter Verhamme, Chantal Visser, Steve P. Watson, Philip Wenzel, Ruth A. L. Willems, Anne Willers, Pengyu Zhang, Konstantinos Zifkos, Anton Jan van Zonneveld

Summary: The Fourth Maastricht Consensus Conference on Thrombosis covered a wide range of topics, including the role of coagulation proteins in cardiovascular disease, novel mechanisms of thrombosis, strategies to limit bleeding risks, hemostasis in extracorporeal systems, and clinical dilemmas in thrombosis and antithrombotic management. The conference also revisited the coagulopathy associated with COVID-19.

THROMBOSIS AND HAEMOSTASIS (2023)

Editorial Material Pharmacology & Pharmacy

From bad to worse: the shortage of fibrinolytics

Lorenz Roger van der Linden, Jens Neefs, Thomas Vanassche, Robin Lemmens, Peter Verhamme

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2023)

Article Hematology

Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag

Saartje Van de Vondel, Christophe Vandenbriele, Gerald Gheysens, Peter Verhamme, Ann Janssens

Summary: We report a case of a patient with chronic immune thrombocytopenia (ITP) who developed catastrophic antiphospholipid antibody syndrome (CAPS) following treatment with avatrombopag. The patient presented with symptoms including headache, nausea, and abdominal pain 3 weeks after initiation of avatrombopag, and diagnostic work-up revealed multiple microvascular thrombotic events. Laboratory tests showed positive antiphospholipid antibodies. The diagnosis of avatrombopag-associated CAPS was made.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Article Biology

Peptidylarginine deiminase 4 and ADAMTS13 activity in Staphylococcus aureus bacteraemia

Caroline P. Martens, Marijke Peetermans, Thomas Vanassche, Peter Verhamme, Marc Jacquemin, Kimberly Martinod

Summary: Staphylococcus aureus infection is associated with increased levels of neutrophil extracellular traps (NETs) and von Willebrand factor (VWF), and with reduced activity of ADAMTS13. Peptidylarginine deiminase 4 (PAD4) contributes to NET formation and inactivates ADAMTS13 in vitro. The levels of PADs correlate with ADAMTS13 activity, with neutrophils as the likely source of PAD activity in S. aureus infection. NETs are positively correlated with PADs and negatively correlated with ADAMTS13 activity.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2023)

Article Hematology

Enoxaparin for Long-Term Therapy of Venous Thromboembolism in Patients with Cancer and Renal Insufficiency

Patricia Siguenza, Juan J. Lopez-Nunez, Conxita Falga, Covadonga Gomez-Cuervo, Antoni Riera-Mestre, Aida Gil-Diaz, Peter Verhamme, Ana Cristina Montenegro, Cristina Barbagelata, Egidio Imbalzano, Manuel Monreal

Summary: This study compared the effectiveness of enoxaparin monotherapy in cancer patients with renal insufficiency using the RIETE registry. The results showed that the incidence of fatal PE was higher than fatal bleeding in patients with severe renal insufficiency receiving recommended doses of enoxaparin.

THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience

Christine Van Laer, Marc Jacquemin, Sarissa Baert, Veerle Labarque, Chantal Thys, Thomas Vanassche, Chris Van Geet, Peter Verhamme, Karen Willekens, Anniek Corveleyn, Kathelijne Peerlinck, Kathleen Freson

Summary: This study focuses on the implementation of genetic testing for inherited bleeding, thrombotic, and platelet disorders in Belgian clinical practice. The results highlight the challenges in interpreting genetic results and suggest the need for continuous optimization of diagnostic outcomes. Variants were reclassified and submitted to the ISTH's GoldVariants database.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Article Clinical Neurology

Long-term outcomes after traumatic brain injury in elderly patients on antithrombotic therapy

Rebeca Alejandra Gavrila Laic, Peter Verhamme, Jos Vander Sloten, Bart Depreitere

Summary: Elderly patients receiving antithrombotic treatment have a higher risk of developing intracranial hemorrhage after traumatic brain injury (TBI), leading to higher mortality rates and worse outcomes. This study aims to investigate injury patterns and long-term outcomes in elderly patients treated with antithrombotic drugs.

ACTA NEUROCHIRURGICA (2023)

Meeting Abstract Peripheral Vascular Disease

OPEN-ANGLE GLAUCOMATOUS OPTIC DAMAGE ASSOCIATED WITH DAYTIME AND NOCTURNAL DIPS IN BLOOD PRESSURE

Jesus D. Melgarejo, Jan Van Eijgen, Dongmei Wei, Gladys E. Maestre, Lama A. Al Aswad, Luis J. Mena, Thomas Vanassche, Stefan Janssens, Peter Verhamme, Karel V. Keer, Ingeborg Stalmans, ZhenYu Zhang

JOURNAL OF HYPERTENSION (2023)

Meeting Abstract Peripheral Vascular Disease

OPEN-ANGLE GLAUCOMATOUS OPTIC DAMAGE IN RELATION TO SYSTEMIC AND OCULAR PERFUSION PRESSURE

Jesus D. Melgarejo, Jan Van Eijgen, Dongmei Wei, Gladys E. Maestre, Lama A. Al Aswad, Luis J. Mena, Thomas Vanassche, Stefan Janssens, Peter Verhamme, ZhenYu Zhang, Karel V. Keer, Ingeborg Stalmans

JOURNAL OF HYPERTENSION (2023)

Meeting Abstract Peripheral Vascular Disease

CARDIOVASCULAR RISK AND METABOLIC CHARACTERIZATION OF METABOLICALLY HEALTHY OBESITY CLASSIFIED BY THE NEWLY PROPOSED DEFINITION: A PROSPECTIVE STUDY

Dongmei Wei, Vannina Gonzalez Marrachelli, Jesus Melgarejo, ChiaTe Liao, Stefan Janssens, Peter Verhamme, Daniel Monleon, Josep Redon, Lucas Van Aelst, Thomas Vanassche, ZhenYu Zhang

JOURNAL OF HYPERTENSION (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Direct puncture versus contralateral femoral artery approach for catheter-directed thrombolysis of occluded infra-inguinal arterial bypass grafts

H. Verelst, L. Bonne, H. Mufty, E. Claus, S. Houthoofd, P. Verhamme, I. Fourneau, G. Maleux

Summary: This study compared the safety and effectiveness of percutaneous direct puncture approach and contralateral femoral native vessel approach for catheter-directed thrombolysis of occluded infra-inguinal bypass grafts. The results showed that the direct puncture approach is a safe and efficient method with comparable clinical outcomes to the native vessel approach. The rate of adverse events was slightly lower in the direct approach group, but without significance.

CLINICAL RADIOLOGY (2023)

Article Hematology

Inhibition of thrombin-activatable fibrinolysis inhibitor via DS-1040 to accelerate clot lysis in patients with acute pulmonary embolism: a randomized phase 1b study

Thomas Vanassche, Rachel P. Rosovsky, Fares Moustafa, Harry R. Buller, Annelise Segers, Indu Patel, Minggao Shi, Naoki Miyoshi, Venkatesh Mani, Zahi Fayad, Dominique Stephan, Jeannot Schmidt, Michael A. Grosso, Victor F. Tapson, Peter Verhamme, M. Huisman

Summary: This study evaluated the tolerability and efficacy of adding DS-1040 in patients with intermediate-risk PE. The results showed that adding DS-1040 did not increase bleeding risk, but also did not improve thrombus resolution or right ventricular dilation.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

No Data Available